AU4134497A - Anti-integrin alpha3 antibody complexes - Google Patents

Anti-integrin alpha3 antibody complexes

Info

Publication number
AU4134497A
AU4134497A AU41344/97A AU4134497A AU4134497A AU 4134497 A AU4134497 A AU 4134497A AU 41344/97 A AU41344/97 A AU 41344/97A AU 4134497 A AU4134497 A AU 4134497A AU 4134497 A AU4134497 A AU 4134497A
Authority
AU
Australia
Prior art keywords
antibody complexes
integrin alpha3
alpha3
integrin
complexes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU41344/97A
Inventor
Toru Hayakawa
Hiromitsu Kawata
Yasuo Sekimori
Keiji Shimizu
Eri Tominaga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of AU4134497A publication Critical patent/AU4134497A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6849—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70546—Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM
AU41344/97A 1996-09-03 1997-09-03 Anti-integrin alpha3 antibody complexes Abandoned AU4134497A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP25088796 1996-09-03
JP8-250887 1996-09-03
PCT/JP1997/003085 WO1998009651A1 (en) 1996-09-03 1997-09-03 ANTI-INTEGRIN α3 ANTIBODY COMPLEXES

Publications (1)

Publication Number Publication Date
AU4134497A true AU4134497A (en) 1998-03-26

Family

ID=17214505

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41344/97A Abandoned AU4134497A (en) 1996-09-03 1997-09-03 Anti-integrin alpha3 antibody complexes

Country Status (2)

Country Link
AU (1) AU4134497A (en)
WO (1) WO1998009651A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1721977A3 (en) * 2001-09-17 2008-10-15 PDL BioPharma, Inc. Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
AU2016258988A1 (en) 2015-05-04 2017-12-07 Cytomx Therapeutics, Inc Anti-ITGa3 antibodies, activatable anti-ITGa3 antibodies, and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0282057A3 (en) * 1987-03-11 1990-03-07 The Board Of Regents Of The University Of Michigan Chemo-radio-immuno-conjugates
WO1992007466A1 (en) * 1990-11-05 1992-05-14 Bristol-Myers Squibb Company Synergistic therapy with combinations of anti-tumor antibodies and biologically active agents
US5578704A (en) * 1992-04-03 1996-11-26 Genentech, Inc. Antibody to osteoclast alphavbeta3 ntegrin
JP4111554B2 (en) * 1993-11-19 2008-07-02 中外製薬株式会社 Reconstituted human antibody against human medulloblastoma cells
EP0729976A1 (en) * 1993-11-19 1996-09-04 Chugai Seiyaku Kabushiki Kaisha Reconstituted human antibody against human medulloblastomatous cell
DK0719859T3 (en) * 1994-12-20 2003-10-20 Merck Patent Gmbh Anti-alpha V integrin monoclonal antibody

Also Published As

Publication number Publication date
WO1998009651A1 (en) 1998-03-12

Similar Documents

Publication Publication Date Title
AU3811495A (en) Antibodies
AU4370697A (en) Coordination system
AU4322797A (en) Protruding case for mail
AU2792197A (en) Microemulsion
AU3576797A (en) Anti-cocaine catalytic antibody
AU2373597A (en) Particulate materials
AU683801B2 (en) Welded carrier improvements
AU5934798A (en) Sorting system
AU6245196A (en) Serving trolley
AU9650398A (en) Piperazine-cyclodextrin complexes
AU3290197A (en) Halopropargyl inclusion complexes
AU1475597A (en) Rapid-freezing container
AU8072498A (en) Heregulin-like factor
AU4134497A (en) Anti-integrin alpha3 antibody complexes
AU3979397A (en) Container
AUPO200596A0 (en) Centre tipper
AU2379397A (en) Container
AU9300898A (en) Integrin ligand dissociators
AU2042997A (en) Iron-casein complexes and methods for preparation thereof
AU4339796A (en) Trolley
AU7623296A (en) Microcellulose-based preparations
AU1344099A (en) Container system
AU1627897A (en) Container
AU7046696A (en) Excavator
AUPN600495A0 (en) Mobile hanger